John Campbell: New cancer treatment
Peer-Reviewed Research
Key Takeaways
- IMM-101 (heat-killed mycobacteria) showed significant improvement in time to progression and overall survival in cancer patients across all cancer types.
- Patients who had previously received BCG vaccine showed even better protective effects when combined with IMM-101.
- Natural polyclonal immunity (from prior infection) may provide superior protection compared to vaccines in some cases.
Notable Quotes
“You can’t beat polyclonal natural immunity.”
Bottom Line
Cancer patients may benefit from exploring IMM-101 immunotherapy, especially if they’ve previously received BCG vaccination, as it showed significant improvements in survival outcomes.
Explore More
- John Campbell’s Full Protocol — supplements, dosages, and daily routine
- Compare All Protocols — side-by-side protocols
Watch the Full Video
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.
Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.
No spam. Unsubscribe anytime. Powered by Beehiiv.
Related Research
From Our Research Network
Daily longevity researchZone2 Training
Exercise protocolsSleep Science
Sleep optimization
Part of the Evidence-Based Research Network